在TP53突变Ewing肉瘤中,非化疗辅助剂是TP53突变的辅助剂
Jin-Ah Kim1, Kenneth A Crawford2, Piero A Spada2
1Children's Cancer Therapy Development Institute, 9025 NE Von Neumann Drive Ste 110, Hillsboro, OR, 97006, USA. jinah@cc-tdi.org.
Scientific reports
|September 1, 2023
概括
埃诺克萨和恩提诺斯塔特作为辅助疗法,有望改善尤文肉瘤 (EWS) 的缓解耐久性. 美国食品和药物管理局 (FDA) 批准的抗生素埃诺克萨辛 (Enoxacin) 已被提议在EWS患者中进行进一步的临床研究.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 尤文肉瘤 (EWS) 是一种罕见的骨和软组织癌症,影响青少年和成年人.
- 复发性EWS缺乏有效的标准治疗,最近的试验未能通过更多的化疗药物改善生存率.
- 对于新的治疗策略来提高EWS的缓解耐久性,有极大的需求.
研究的目的:
- 调查非化疗辅助药物候选人用于EWS的组合治疗.
- 为了确定潜在的药物,可以延长缓解耐久性超越标准化疗.
主要方法:
- 在体外有效性评估使用固依赖和固独立生长试验.
- 在EWS异种移植小鼠模型中对候选药物的体内评估.
- 对三种新的辅助药物候选药物的查与化疗相结合.
主要成果:
- 埃诺克萨和恩丁诺斯塔特作为辅助疗法表现出最显著的疗效.
- 这两种药物在长期的体外和体内研究中都显示出有效性.
- 美国食品和药物管理局 (FDA) 批准的抗生素埃诺克萨 (Enoxacin) 和实验性药物恩提诺斯塔特 (entinostat) 被确定为主要候选药物.
结论:
- 伊诺克萨和恩丁诺斯塔特是对尤文肉瘤的有效辅助药物候选药物.
- 因其FDA批准和已证明的有效性,Enoxacin被提议进行进一步的临床前和临床研究.
- 使用埃诺素辅助治疗可能提供一种新的策略,以改善EWS患者的治疗结果.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
01:15Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
01:10Drugs that Destabilize Microtubules
2.0K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K